Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: A role for the W1W2 repeat domain

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 6619-6628

  Nitsche, Fiona ^a   Bell, Andrew ^a   Rickinson, Alan ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MUTANT PROTEIN; SYNAPSIN I; VIRUS PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; EPSTEIN BARR VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CELL TRANSFORMATION;

EID: 0030795035     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.6619-6628.1997     Document Type: Article

References (58)

1. Abbot, S. D., M. Rowe, K. Cadwallader, J. Gordon, A. Ricksten, L. Rymo, and A. B. Rickinson. 1990. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-coded latent membrane protein. J. Virol, 64:2126-2134.
2. Alfieri, C. M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:505-608.
3. Allan, G. J., G. J. Inman, B. D. Parker, D. T. Rowe, and P. J. Farrell. 1992. Cell growth effects of Epstein-Barr virus leader protein. J. Gen. Virol. 73: 1547-1551.
4. Brooks, L., Q. Y. Yao, A. B. Rickinson, and L. S. Young. 1992. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 66:2689-2697.
5. Carvalho, T., J.-S. Seeler, K. Ohman, P. Jordan, U. Pettersson, G. Akusjarvi, M. Carmo-Fonseca, and A. Dejean. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
6. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff, 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
7. Cordier, M. A., A. Calender, M. Billaud, U. Zimber, G. Rousseltet, O. Paulish, J. Banchereau, T. Tursz, G. Bornkamm, and G. M. Lenoir. 1990. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expansion of B-cell activation molecules CD21 and CD23. J. Virol. 64:1002-1013.
8. Everett, R. D., and G. G. Maul, 1994, HSV-1 IE protein Vmw 110 causes redistribution of PML. EMBO J. 13:5062-5069.
9. Everett, R. D., C. M. Preston, and N. D. Stow. 1991. Functional and genetic analysis of the role of Vmw 110 in herpes simplex virus replication, p. 49-76. In E. K. Wagner (ed.), Herpes virus transcription and its regulation. CRC Press Inc., Boca Raton, Fla.
10. Finke, J., M. Rowe, B. Kallin, I. Ernberg, A. Rosén, J. Dillner, and G. Klein. 1987. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. J. Virol. 61:3870-3878.
11. Green, S., I. Issemann, and E. Sheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
12. Grossman, S. R., E. Johannsen, X. Tong, R. Yalamanchili, and E. Kieff. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the Jκ recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91:7568-7572.
13. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalising functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
14. Harada, S., and E. Kieff. 1997. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation, J. Virol. 71:6611-6618.
15. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Long-necker, E. Kieff, and A. B. Rickinson. 1991. Induction of bel-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
16. Henkel, T., P. D. Ling, S. D. Hayward, and M. G. Petersen. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein Jκ. Science 265:92-95.
17. Inman, G. J., and P. J. Farrell. 1995. Epstein-Barr virus EBNA-LP and transcriptional regulation properties of pRB, p107 and p53 in transfection assays. J. Gen. Virol. 76:2141-2149.
18. Jiang, W.-Q., L. Szekely, V. Wendel-Hansen, N. Ringertz, G. Klein, and A. Rosen. 1991. Co-localisation of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA5. Exp. Cell Res, 197:314-318.
19. Johansen, E., E. Kuh, G. Mosialos, X. Tong, E. Kieff, and S. R. Grossman. 1995. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by Jκ and PU.1. J. Virol. 69:253-262.
20. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstcin-Barr virus latent membrane protein 1 is essential for B-lymphocytc growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
21. Kempkes, B., D. Pich, R. Zeidler, B. Sugden, and W. Hammerschmidt. 1995. Immortalization of human B lymphocytes by a plasmid containing 71 kilo-base pairs of Epstein-Barr virus DNA. J. Virol. 69:231-238.
22. Kieff, E. 1996. Epstein-Barr virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, Pa.
23. Kitay, M. K., and D. T. Rowe. 1996. Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP. J. Virol. 70: 7885-7893.
24. Kitay, M. K., and D. T. Rowe. 1996. Protein-protein interactions between Epstein-Barr virus nuclear antigen-LP and cellular gene products: binding of 70-kilodalton heat shock proteins. Virology 220:91-99.
25. Knutson, J. C. 1990. The level of c-fgr RNA is increased by EBNA2, an Epstein-Barr virus gene required for B-cell immortalization. J. Virol. 64: 2350-2356.
26. Laux, G., F. Dugrillon, C. Eckert, B. Adam, U. Zimber-Strobl, and G. W. Bornkamm. 1994. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J. Virol. 68:6947-6958.
27. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini. and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
28. Mannick, J. B., X. Tong, A. Hennes, and E. Kieff. 1995. The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsp73. J. Virol. 69:8169-8172.
29. Marshall, D., and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
30. Mosiaios, G., M. Birkenbach, R. Yalamanchili, T. Van Arsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signalling proteins from the tumor necrosis factor receptor family. Cell 80:389-399.
31. Murray, R. J., L. S. Young, A. Calender, C. D. Gregory, M. Rowe, G. M. Lenoir, and A. B. Rickinson. 1988. Different patterns of Epstein-Burr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains. J. Virol. 62:894-901.
32. 31a.Nitsche, F. Unpublished observation.
33. Petti, L., C. Sample, and E. Kieff. 1990. Suhnuclear localization and phosphorylution of Epstein-Barr virus Intent infection nuclear proteins. Virology 176:563-574.
34. Robertson. E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, B. Tomkinson, and E. Kieff. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-hinding protein Jκ. J. Virol. 69:3108-3116.
35. Robertson. E. S., J. Lin, and E. Kieff. 1996. The amino-tcrminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, nd 3C interact with RBPJκ. J. Virol. 70:3008-3074.
36. Rooney, C. M., C. D. Gregory, M. Rowe, S. Finerty, C. F. Edwards, H. Rupani, and A. B. Rickinson. 1986, Endemic Burkitt's lymphoma: phenotypic analysis of Burkitt's lymphoma biopsy cells and of the derived tumour cell lines. J. Natl. Cancer Inst. 77:681-687.
37. Rowe, M., H. S. Evans, L. S. Young, K. Hennessy, E. Kieff, and A. B. Rickinson. 1987. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 68:1575-1586.
38. Rowe, M., R. Khanna, C. A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S. R. Burrows, J. Trowsdale, D. J. Moss, and A. B. Rickinson. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: co-ordinate up-regulation of peptidc transporters and HLA class I antigen expression. Eur. J. Immunol. 25:1374-1384.
39. Rowe, M., D. T. Rowe, C. D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743-2751.
40. Sample, J., M. Hummel, D. Braun, M. Birkenbach, and E. Kieff. 1986. Nuclcotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site. Proc. Natl. Acad, Sci. USA 83:5019-5100.
41. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13:3321-3328.
42. Sung, N. S., S. Kenney, D. Gutsch, and J. S. Pagano. 1991. EBNA2 transactivatcs a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J. Virol. 65:2164-2169.
43. Szekely, L., W.-Q. Jiang, K. Pokrovskaja, K. G. Wiman, G. Klein, and N. Ringertz. 1995. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA5 and hsp 70 proteins after exposure to heat shock or cell density congestion. J. Gen. Virol. 76:2423-2432.
44. Szekely, L., K. Pokrovskaja, W.-Q. Jiang, H. de The, N. Ringertz, and G. Klein. 1996. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70:2562-2568.
45. Szekely, L., K. Pokrovskaja, W.-Q. Jiang, G. Selivnnova, M. Lowbeer, N. Ringertz, K. G. Wiman, and G. Klein. 1995. Resting B-cells, EBV-infected B-blasts and established lymphoblastoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Oncogene 10:1869-1874.
46. Szekdy, L., G. Selivanova, K. P. Magnusson, G. Klein, and K. G. Wimam. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins, Proc. Natl. Acad. Sci. USA 90:5455-5459.
47. Takudu, K., and Y. Ono. 1989, Synchronous and sequential activation of latently infected Mein-Barr virus genomes. J. Virol. 63:445-449.
48. Tomkinson, B., and E. Kieff. 1992. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein EBNA3B is not essential for B-lymphocyte infection or growth transformation in vitro. J. Virol. 66:2893-2903.
49. Tomkinson, B., E. Robertson, and E, Kieff. 1993. Epstein-Barr virus nuclear proteins (EBNA) 3A and 3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
50. Wang, F., C. Gregory, J. Sample, M. Rowe, D. Liebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
51. Wang, F., L. Petti, D. Braun, S. Seung, and E. Kieff. 1987. A bicistronic Epstein-Burr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. J. Virol. 61:945-954.
52. Wang, F., S.-F. Tsang, M. G. Kurilla, J. J. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:3407-3416.
53. Woisetschlaeger, M., C. N. Yandava, L. A, Furmanski, J. L. Strominger, and S. H. Speck, 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 87:1725-1729.
54. Yates, J., N. Warren, D. Reisman, and B. Sugden, 1984, A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently-infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
55. Young, L., C. Alfieri, K. Hennessy, H. Evans, C. O'Hara, K. C. Anderson, J. Ritz, R. S. Shapiro, A. Rickinson, E. Kieff, and J. L Cohen. 1989. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease, N. Engl. J. Med. 321:1080-1085.
56. Zhao, B., D. R. Marshall, and C. E. Sample. 1996. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ. J. Virol. 70:4228-4236.
57. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Hong, and G. W. Bornkamm. 1994. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-Jk, the homologue of Drosophila suppressor of hairless. EMBO J. 13:4973-4982.
58. Zimber-Strobl, U., K.-O. Suentzenich, G. Laux, E. Eick, M. Cordier, A. Calender, M. Billaud, G. M. Lenoir, and G. W. Bornkamm. 1991. EpsteinBarr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65:415-423.